Similarly, after radiation therapy, OS was significantly better in the WHO grade 4 IDH-mutant astrocytoma than in the IDH-wildtype GBM, and mOS was 30.6 months versus 15.0 months, respectively (P = 0.0125). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).